Cardiovascular Toxicology & Pharmacology

Cardiovascular pharmacology deals with the treatment of heart disease. Cardiac medications are used to treat the cardiac, circulatory and vascular system. Various cardiovascular agents are available to treat various cardiovascular conditions. Sodium, potassium, calcium channel blockers, ACE inhibitors and cardiac biomarkers. Cardiovascular Toxicology is the field which essentially focuses to the antagonistic impacts on the heart or blood frameworks that outcome from presentation to lethal synthetic compounds. It expounds wellbeing information of unfavorable impacts of new cardiovascular meds. Pharmacology of vascular endothelium manages alterations of endothelial cells and the vasculature have a pivotal influence in the pathogenesis of a wide scope of the most appalling of human illnesses, as endothelial cells have the imperative job of taking an interest in the upkeep of patent and useful vessels.

  • Novel anti-inflammatory therapies for atherosclerosis
  • Drug-induced cardiac toxicity
  • Development of novel anti-ischemic agents
  • Biomarkers

Related Conference of Cardiovascular Toxicology & Pharmacology

December 18-18, 2020

3rd Annual Conference on Epidemiology and Public Health

Singapore City, Singapore
January 04-04, 2021

7th Global Summit on Heart Care and Diseases

London, UK
March 16-17, 2021

4th International Conference on Ear Nose and Throat

Sydney, Australia
March 22-23, 2021

7th World Congress on Anesthesia and Critical Care

Paris, France
March 23-24, 2021

2nd Annual Congress on Medicine

Tokai, Japan
April 19-20, 2021

8th Asian Herbal and Traditional Medicine summit

Tokyo, Japan

Cardiovascular Toxicology & Pharmacology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in